Ucb Biopharma Srl

This study is following up with people who have generalized myasthenia gravis (gMG) to see how safe and effective the drug zilucoplan is over a longer period. It is for 200 participants who have already completed a previous zilucoplan trial. The main goal is to monitor side effec…

This study aims to check the long-term safety and side effects of repeated treatment cycles with the drug rozanolixizumab in children aged 2 and older who have generalized myasthenia gravis (gMG). It is an extension study for children who completed a previous trial, allowing them…

This study is checking the long-term safety and effectiveness of an injectable medication called bimekizumab for adults with active psoriatic arthritis. Over 1,100 participants who completed earlier trials will receive the drug for an extended period. The main goal is to see how …

This study compares two medications, bimekizumab and risankizumab, to see which works better for adults with active psoriatic arthritis. Researchers will measure improvements in joint pain, swelling, skin symptoms, and daily function after 16 weeks of treatment. The trial include…

This study is testing a medication called certolizumab pegol in children and teenagers aged 6 to 17 who have moderate to severe plaque psoriasis. The main goals are to understand how the drug behaves in young bodies and to check its safety. It is a Phase 3 trial, which means rese…

This study is testing whether a medication called brivaracetam can safely and effectively control absence seizures in children and young adults aged 2 to 25. Absence seizures cause brief lapses in awareness. The trial involves 153 participants and compares different doses of the …

This study continues testing an experimental lupus medication called dapirolizumab pegol to check its long-term safety and side effects. It involves 760 people with systemic lupus erythematosus who previously participated in related studies. The main goal is to monitor patients f…

This study is testing an investigational drug called rozanolixizumab to see if it can prevent relapses and control symptoms in adults with MOG antibody-associated disease (MOG-AD), a rare neurological condition. The trial will involve about 104 participants who will receive eithe…

This study aims to check the long-term safety of the drug bimekizumab in people with moderate to severe hidradenitis suppurativa (HS), a chronic and painful skin condition. It is an extension study for 658 participants who completed a previous bimekizumab trial. The main goal is …

This study is giving children with a rare autoimmune muscle-weakening disease an extra year of an experimental drug to check its long-term safety. It's open to kids aged 2 and up who finished a previous trial and whose doctors think they could benefit from continuing treatment. T…

This study aims to check the long-term safety and side effects of an inhaled medication called Staccato alprazolam for stopping prolonged epileptic seizures. It will involve about 300 people aged 12 and older who have already tried this medication in a previous study. The main go…

This study is testing the long-term safety and effectiveness of an investigational drug called bimekizumab for people with active axial spondyloarthritis, a group of painful inflammatory diseases that primarily affect the spine and joints. The trial includes 508 participants who …